The success of this study could revolutionize the standard HIV care for patients in Africa and reduce HIVrelated mortality rates. The REVIVE study is a collaborative research trial between the University of Cape Town and the Population Health Research Institute aimed at testing the effectiveness of a costeffective antibiotic treatment for advanced HIV patients. The trial, funded by the Bill & Melinda Gates Foundation, aims to investigate if administering the antibiotic azithromycin daily over a fourweek period can significantly lower death rates among adults suffering from advanced HIV.
